Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. [electronic resource]
Producer: 20040817Description: L344-51 p. digitalISSN:- 1040-0605
- Administration, Inhalation
- Animals
- Animals, Newborn
- Bronchopulmonary Dysplasia -- drug therapy
- Enzyme Inhibitors -- pharmacology
- Female
- Humans
- Hypertension, Pulmonary -- drug therapy
- Indoles -- pharmacology
- Infant, Newborn
- Nitric Oxide -- pharmacology
- Nitric Oxide Synthase -- metabolism
- Nitric Oxide Synthase Type III
- Pregnancy
- Pulmonary Alveoli -- drug effects
- Pyrroles -- pharmacology
- Rats
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.